XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 29, 2024
Oct. 01, 2023
Sep. 29, 2024
Oct. 01, 2023
Income Statement [Abstract]        
Net revenue [1] $ 182,854 $ 197,845 $ 491,340 $ 552,166
Cost of revenue 126,371 128,911 354,797 368,550
Gross profit 56,483 68,934 136,543 183,616
Operating expenses:        
Research and development 20,905 20,738 60,983 63,703
Sales and marketing 31,196 30,865 91,482 97,226
General and administrative 8,357 16,364 45,610 49,136
Litigation reserves, net (100,855) 178 (92,625) 178
Restructuring and other charges 1,072 366 3,792 2,703
Intangibles impairment 0 1,071 0 1,071
Total operating expenses (39,325) 69,582 109,242 214,017
Income (loss) from operations 95,808 (648) 27,301 (30,401)
Other income, net [2] 3,485 2,280 9,048 11,685
Income (loss) before income taxes 99,293 1,632 36,349 (18,716)
Provision for income taxes 14,219 86,431 15,100 84,382
Net income (loss) $ 85,074 $ (84,799) $ 21,249 $ (103,098)
Net income (loss) per share        
Basic $ 2.96 $ (2.87) $ 0.73 $ (3.52)
Diluted $ 2.9 $ (2.87) $ 0.72 $ (3.52)
Weighted average shares used to compute net income (loss) per share:        
Basic 28,705 29,524 28,992 29,266
Diluted 29,364 29,524 29,389 29,266
[1] No individual foreign country represented more than 10% of the Company’s total net revenue in the periods presented.
[2] Amounts included gain/(loss), net from derivatives not designated as hedging instruments of $(1.6) million and $0.5 million, for the three and nine months ended September 29, 2024, respectively, and $1.3 million and $2.2 million, for the three and nine months ended October 1, 2023, respectively, and gain/(loss), net from a litigation settlement of $6.0 million for the nine months ended October 1, 2023.